NO974500D0 - Blandinger og fremgangsmåter for inhibering av trombogenese - Google Patents

Blandinger og fremgangsmåter for inhibering av trombogenese

Info

Publication number
NO974500D0
NO974500D0 NO974500A NO974500A NO974500D0 NO 974500 D0 NO974500 D0 NO 974500D0 NO 974500 A NO974500 A NO 974500A NO 974500 A NO974500 A NO 974500A NO 974500 D0 NO974500 D0 NO 974500D0
Authority
NO
Norway
Prior art keywords
compounds
methods
inhibiting thrombogenesis
thrombogenesis
inhibiting
Prior art date
Application number
NO974500A
Other languages
English (en)
Other versions
NO974500L (no
Inventor
Jeffrey I Weitz
Jack Hirsh
Edward Young
Original Assignee
Hamilton Civic Hospitals Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hamilton Civic Hospitals Res filed Critical Hamilton Civic Hospitals Res
Publication of NO974500D0 publication Critical patent/NO974500D0/no
Publication of NO974500L publication Critical patent/NO974500L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO974500A 1995-03-31 1997-09-29 Blandinger og fremgangsmåter for inhibering av trombogenese NO974500L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41233295A 1995-03-31 1995-03-31
PCT/CA1996/000190 WO1996029973A2 (en) 1995-03-31 1996-03-29 Compositions and methods for inhibiting thrombogenesis

Publications (2)

Publication Number Publication Date
NO974500D0 true NO974500D0 (no) 1997-09-29
NO974500L NO974500L (no) 1997-11-28

Family

ID=23632577

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974500A NO974500L (no) 1995-03-31 1997-09-29 Blandinger og fremgangsmåter for inhibering av trombogenese

Country Status (8)

Country Link
US (1) US5744457A (no)
JP (2) JPH11506420A (no)
KR (1) KR19980703628A (no)
CN (1) CN1186502A (no)
AU (1) AU5140096A (no)
CA (1) CA2217054C (no)
NO (1) NO974500L (no)
WO (1) WO1996029973A2 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2293595A1 (en) * 1997-06-06 1998-12-10 Hamilton Civic Hospitals Research Development, Inc. Modified low molecular weight heparin that inhibits clot associated coagulation factors
EP1033375A4 (en) 1997-11-20 2002-04-24 Ikuo Yamashina MODIFICATION OF LOW MOLECULAR MASS HEPARIN AND REMEDY FOR SKIN Ulcer
AU759264B2 (en) * 1998-05-27 2003-04-10 Euro-Celtique S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the upper respiratory tract and/or the ear
US6388060B1 (en) 1998-11-06 2002-05-14 Vascular Therapeutics Inc. Process for the sulfation of uronic acid-containing polysaccharides
WO2000067771A1 (en) * 1999-05-06 2000-11-16 The Burnham Institute Antiangiogenic endostatin peptides, endostatin variants and methods of use
IL147318A0 (en) * 1999-06-30 2002-08-14 Hamilton Civic Hospitals Res Heparin compositions that inhibit clot associated coagulation factors
JP2002097143A (ja) * 2000-07-18 2002-04-02 Koyo Chemical Kk 血流改善剤及び血栓予防治療剤または食品
AU2001291549A1 (en) * 2000-09-08 2002-03-22 Hamilton Civic Hospitals Research Development Inc. Antithrombotic compositions
KR100378109B1 (ko) * 2000-10-24 2003-03-29 주식회사 메디프렉스 소수성 다중복합 헤파린 결합체, 그의 제조방법 및 용도
JP2005505537A (ja) * 2001-08-28 2005-02-24 レオ・ファーマ・アクティーゼルスカブ 低分子量ヘパリンと低分子量デルマタン硫酸とを含む抗血栓組成物
AU2003230985A1 (en) * 2002-04-18 2003-11-03 Stephen H. Embury Method and composition for preventing pain in sickle cell patients
EP1663299A4 (en) * 2003-08-12 2009-09-16 Hamilton Civic Hospitals Res PROCESS FOR PREVENTING NEUROLOGICAL EVENTS
US8740797B2 (en) * 2005-06-22 2014-06-03 The Jikei University Ultrasonic therapeutic apparatus
FR2889078B1 (fr) * 2005-07-27 2007-11-02 Aventis Pharma Sa Nouvelle methode de chromatographie d'affinite d'antithrombine iii
AU2007267561B2 (en) * 2006-05-25 2012-05-17 Momenta Pharmaceuticals, Inc. Low molecular weight heparin composition and uses thereof
CN101842392B (zh) * 2007-11-02 2014-08-27 动量制药公司 非抗凝血剂的多糖组合物
US9351992B2 (en) 2007-11-02 2016-05-31 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
US8592393B2 (en) 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
US20110076729A1 (en) * 2008-02-20 2011-03-31 Momenta Pharmaceuticals, Inc. Methods of making low molecular weight heparin compositions
CA2795360A1 (en) 2010-04-16 2011-10-20 Momenta Pharmaceuticals, Inc. Tissue targeting
EP2582355A2 (en) 2010-06-17 2013-04-24 Momenta Pharmaceuticals, Inc. Methods and compositions for promoting hair growth
LT2794665T (lt) * 2011-12-19 2017-12-27 Dilafor Ab Neantikoaguliaciniai glikozaminoglikanai, apimantys pasikartojantį disacharido vienetą, ir jų medicininis panaudojimas
WO2013147689A1 (en) * 2012-03-26 2013-10-03 Dilafor Ab Combination treatment comprising sulphated glycosaminoglycans for inducing labor
JP2016520613A (ja) 2013-05-28 2016-07-14 モメンタ ファーマシューティカルズ インコーポレイテッド 薬学的組成物
CN108424474B (zh) * 2017-02-15 2023-07-25 清华大学 去抗凝肝素衍生物及其用于炎症性肠病的治疗

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4500519A (en) * 1978-11-06 1985-02-19 Choay S.A. Mucopolysaccharides having biological properties, preparation and method of use
US4281108A (en) * 1980-01-28 1981-07-28 Hepar Industries, Inc. Process for obtaining low molecular weight heparins endowed with elevated pharmacological properties, and product so obtained
US4351938A (en) * 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
FR2503714B1 (fr) * 1981-04-10 1986-11-21 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
ZA829463B (en) * 1982-07-19 1983-10-26 Hepar Ind Inc Process for manufacturing low molecular weight heparins by depolymerization of normal heparin
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
US4687765A (en) * 1983-07-25 1987-08-18 Choay S.A. Method and composition for thrombolytic treatment
US4847338A (en) * 1985-03-28 1989-07-11 University Of Iowa Research Foundation Low molecular weight heparin fragments as inhibitors of complement activation
US4916219A (en) * 1985-03-28 1990-04-10 University Of Iowa Research Foundation Oligosaccharide heparin fragments as inhibitors of complement cascade
FR2584728B1 (fr) * 1985-07-12 1987-11-20 Choay Sa Procede de sulfatation de glycosaminoglycanes et de leurs fragments
US5106734A (en) * 1986-04-30 1992-04-21 Novo Nordisk A/S Process of using light absorption to control enzymatic depolymerization of heparin to produce low molecular weight heparin
DK196886D0 (da) * 1986-04-30 1986-04-30 Novo Industri As Fremstilling af polysaccharider
US4942156A (en) * 1986-08-20 1990-07-17 Hepar Industries, Inc. Low molecular weight heparin derivatives having improved anti-Xa specificity
ES2003197A6 (es) * 1987-01-05 1988-10-16 Rovi Lab Farmaceut Sa Procedimiento de despolimerizacion de la heparina para la obtencion de una heparina de bajo peso molecular dotada de actividad antitrombotica
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
EP0337327A1 (en) * 1988-04-09 1989-10-18 Bioiberica, S.A. Process for the preparation of new oligosaccharide fractions by controlled chemical depolimerization of heparin
IT1234508B (it) * 1988-06-10 1992-05-19 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
US4981955A (en) * 1988-06-28 1991-01-01 Lopez Lorenzo L Depolymerization method of heparin
DE68904264T2 (de) * 1988-08-24 1993-05-27 Akzo Nv Fragmente und fraktionen von heparin mit wirkung gegen hiv.
IT1230582B (it) * 1988-10-21 1991-10-28 Opocrin S P A Lab Farmabiologi Oliogosaccaridi di dermatan solfato ed eparina aventi attivita' antiaterosclerotica
GB8826448D0 (en) * 1988-11-11 1988-12-14 Thrombosis Res Inst Improvements in/relating to organic compounds
AU7742591A (en) * 1990-04-06 1991-10-30 Washington University Anticoagulant oligosaccharides
SE9002550D0 (sv) * 1990-08-01 1990-08-01 Kabivitrum Ab Heparinfragment
IT1243300B (it) * 1990-12-20 1994-05-26 Fidia Spa Derivati dell'eparina
IT1244373B (it) * 1991-01-18 1994-07-08 Sclavo Spa Composizioni farmaceutiche per uso orale contenenti eparina a basso peso molecolare, loro preparazione ed uso
US5280016A (en) * 1991-03-29 1994-01-18 Glycomed Incorporated Non-anticoagulant heparin derivatives
AU1680692A (en) * 1991-03-29 1992-11-02 Glycomed Incorporated Modulation of tpa activity by heparin fragments
US5250519A (en) * 1991-03-29 1993-10-05 Glycomed Incorporated Non-anticoagulant heparin derivatives
SE9101155D0 (sv) * 1991-04-18 1991-04-18 Kabi Pharmacia Ab Novel heparin derivatives
FR2675806B1 (fr) * 1991-04-23 1994-06-10 Rhone Poulenc Rorer Sa Polysaccharides sulfates, procede de preparation, composition pharmaceutique et utilisation.
IT1245907B (it) * 1991-05-17 1994-10-25 Alfa Wassermann Spa Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.
IT1251183B (it) * 1991-08-28 1995-05-04 Opocrin Spa Dermatan solfato ad alto titolo, dotato di elevata attivita' trombolitica, e forme farmaceutiche che lo contengono.
FR2687158B1 (fr) * 1992-02-07 1995-06-30 Rhone Poulenc Rorer Sa Polysaccharides sulfates, procede de preparation, composition pharmaceutique et utilisation.
SE9200951D0 (sv) * 1992-03-27 1992-03-27 Kabi Pharmacia Ab Pharmaceutical composition containing a defined lipid system
US5389539A (en) * 1992-11-30 1995-02-14 Massachusetts Institute Of Technology Purification of heparinase I, II, and III from Flavobacterium heparinum
FR2704861B1 (fr) * 1993-05-07 1995-07-28 Sanofi Elf Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.
SE9303612D0 (sv) * 1993-11-02 1993-11-02 Kabi Pharmacia Ab New use

Also Published As

Publication number Publication date
AU5140096A (en) 1996-10-16
CN1186502A (zh) 1998-07-01
JPH11506420A (ja) 1999-06-08
CA2217054C (en) 2009-02-17
CA2217054A1 (en) 1996-10-03
WO1996029973A2 (en) 1996-10-03
KR19980703628A (ko) 1998-12-05
NO974500L (no) 1997-11-28
JP2007204500A (ja) 2007-08-16
US5744457A (en) 1998-04-28
MX9708378A (es) 1998-10-31
WO1996029973A3 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
NO974500L (no) Blandinger og fremgangsmåter for inhibering av trombogenese
NO973836D0 (no) Benzopyran-inneholdende forbindelser og fremgangsmåte for anvendelse derav
NO952669D0 (no) Fremgangsmåte til behandling av seismiske data
NO960019D0 (no) Fremgangsmåte og system for oppveiing av porsjoner
DE69529921D1 (de) Bewegungsunterstütztes weiterreichungsverfahren
NO953546L (no) Ekspanderende trekkbar broplugg
NO980507D0 (no) Nedihullsapparat
NO973464D0 (no) Forlengingsrör - avskraperpluggapparat og fremgangsmåte
DE69632757D1 (de) Aufzeichnungsgerät
NO973009D0 (no) Fremgangsmåte for å inhibere kathepsin-k
NO943763D0 (no) 4-arylamino-benzopyraner og beslektede forbindelser
NO971710L (no) Fremgangsmåte for inversjon av seismiske data
DE69627775D1 (de) Aufzeichnungsgerät
NO994599D0 (no) Anordning og fremgangsmaate for prosodigenering av visuell syntese
ID18300A (id) Metoda penemperan
NO975699L (no) Fremgangsmåte for oksyklorering
ID16924A (id) Metode perlakuan poliolefin
NO990018D0 (no) Belegg og fremgangsmÕte for fremstilling derav
BR9610514A (pt) Inibidores cicloantihelmínticos
DE69613771D1 (de) Aufzeichnungsgerät
NO961493L (no) Stötteanordning og fremgangsmåte for tilvirkning av slike
IS4339A (is) Hömlun ljóssundurliðunar á 3-setnum-2-oxindólum
KR950004860U (ko) 조립식 오디오용 플러그
UA25398A (uk) Спосіб комбіhоваhої холецистолітотомії
UA25653A (uk) Спосіб проведеhhя скальптерапії